Evolent Health, Inc.
EVH
$2.99
-$0.07-2.29%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 468.72M | 479.53M | 444.33M | 483.65M | 646.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 468.72M | 479.53M | 444.33M | 483.65M | 646.54M |
| Cost of Revenue | 371.47M | 379.76M | 343.94M | 381.18M | 570.83M |
| Gross Profit | 97.25M | 99.77M | 100.39M | 102.47M | 75.71M |
| SG&A Expenses | 61.86M | 75.50M | 74.42M | 76.71M | 46.98M |
| Depreciation & Amortization | 45.04M | 23.62M | 23.14M | 24.06M | 7.70M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 478.36M | 478.88M | 441.50M | 481.95M | 625.51M |
| Operating Income | -9.64M | 658.00K | 2.83M | 1.70M | 21.03M |
| Income Before Tax | -430.81M | -19.96M | -20.72M | -63.15M | -23.92M |
| Income Tax Expenses | -1.68M | 906.00K | -825.00K | 1.47M | -1.12M |
| Earnings from Continuing Operations | -429.13M | -20.86M | -19.90M | -64.62M | -22.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -429.13M | -20.86M | -19.90M | -64.62M | -22.80M |
| EBIT | -9.64M | 658.00K | 2.83M | 1.70M | 21.03M |
| EBITDA | 29.70M | 18.67M | 20.37M | 19.46M | 22.43M |
| EPS Basic | -3.65 | -0.24 | -0.44 | -0.63 | -0.36 |
| Normalized Basic EPS | -0.16 | -0.08 | -0.04 | -0.32 | 0.09 |
| EPS Diluted | -3.65 | -0.24 | -0.44 | -0.63 | -0.36 |
| Normalized Diluted EPS | -0.16 | -0.08 | -0.04 | -0.32 | 0.09 |
| Average Basic Shares Outstanding | 111.61M | 114.07M | 115.88M | 115.32M | 115.03M |
| Average Diluted Shares Outstanding | 111.61M | 114.07M | 115.88M | 115.32M | 115.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | -9.25% | -23.22% | -7.08% | -21.08% |